Immunotherapy News and Research

Latest Immunotherapy News and Research

AI-based population screening could expedite the diagnosis of pancreatic cancer

An artificial intelligence tool has successfully identified people at the highest risk for pancreatic cancer up to three years before diagnosis using solely the patients' medical records, according to new research led by investigators at Harvard Medical School and the University of Copenhagen, in collaboration with VA Boston Healthcare System, Dana-Farber Cancer Institute, and the Harvard T.H. Chan School of Public Health.

8 May 2023

People with Long COVID neurological symptoms found to have differences in immune cell profiles and autonomic dysfunction

Twelve people with persistent neurological symptoms after SARS-CoV-2 infection were intensely studied at the National Institutes of Health (NIH) and were found to have differences in their immune cell profiles and autonomic dysfunction.

5 May 2023

HIPEC: A promising treatment for certain patients with Stage IV abdominal cancer

A technique that delivers high doses of heated chemotherapy directly to the abdominal cavity is a promising treatment for certain patients with Stage IV cancer.

5 May 2023

Breast cancer tumors disrupt the development of an immune response to favor their own growth

Researchers at Baylor College of Medicine and collaborating institutions have identified a strategy cancerous tumors use to remotely disrupt the development of an immune response that could stop their growth.

5 May 2023

Cancer stem cell test can lead to increased survival for patients with glioblastoma

New multi-institutional phase 3 clinical trial data published May 2 in Cell Reports Medicine found that a cancer stem cell test can accurately decide more effective treatments and lead to increased survival for patients with glioblastoma, a deadly brain tumor.

5 May 2023

Wistar scientists uncover a key mechanism as to how p53 suppresses tumors

The p53 gene is one of the most important in the human genome: the only role of the p53 protein that this gene encodes is to sense when a tumor is forming and to kill it.

5 May 2023

Study finds a pharmacological-based approach to revert immune escape of breast cancer cells

Freiburg researchers discover a mechanism by which cancer cells escape the immune system.

4 May 2023

Study pinpoints how gut microbes boost the body's response to cancer immunotherapy

Cancer immunotherapy has transformed the treatment of many types of cancer. Yet, for reasons that remain poorly understood, not all patients get the same benefit from these powerful therapies.

4 May 2023

New approach for efficient engineering of cell and gene therapies

A new approach to the genetic engineering of cells promises significant improvements in speed, efficiency, and reduction in cellular toxicity compared to current methods.

28 Apr 2023

Testing hundreds of existing therapeutics to fight blood cancer more effectively

Multiple myeloma is a rare blood cancer caused by the uncontrolled multiplication of abnormal plasma cells.

27 Apr 2023

Unique treatment can eradicate pancreatic tumors while stopping cancer progression

A unique treatment combining radiation and immunotherapy can eradicate pancreatic tumors while stopping the cancer from spreading, according to a new study by researchers at the University of Colorado Cancer Center.

27 Apr 2023

Melanoma research unveils landscape of DNA and RNA alterations across multiple organs of metastasis

In a new translational study from UCLA Jonsson Comprehensive Cancer Center, researchers analyzed genetic changes in the organs of recently deceased patients to understand how metastatic cutaneous melanoma spreads in those who had initially benefited from precision therapies.

27 Apr 2023

Biomarker signature test can predict tumor response to bladder cancer immunotherapy

In a discovery that could improve the survival of bladder cancer patients, Northwestern Medicine scientists have developed a biomarker signature test to predict which tumors will respond to immunotherapy.

27 Apr 2023

Developing Next-Generation Nanomaterials for Medical Applications

In this interview conducted at Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to Dr. Chad Merkin, Director of the International Institute for Nanotechnology, about his work developing next-generation nanomaterials for medical applications.

From Pittcon 27 Apr 2023

Spatial organization of immune cells predicts outcomes for patients with clear cell renal cell carcinoma

Outcomes for patients with clear cell renal cell carcinoma have improved over the past decade due to the approval of immunotherapies, yet still there is a subset of patients who do not respond to this type of therapy.

26 Apr 2023

Research uncovers antibodies that are still effective against new variants of SARS-CoV-2

An anonymous San Diego resident has become a fascinating example of how the human immune system fights SARS-CoV-2.

26 Apr 2023

ASTRO/ESTRO's clinical guideline offers recommendations on the use of local therapy for oligometastatic NSCLC

A new clinical guideline from the American Society for Radiation Oncology and European Society for Radiotherapy & Oncology provides guidance on the use of definitive local therapy-; including radiation and surgery-; to treat patients with oligometastatic non-small cell lung cancer (NSCLC).

25 Apr 2023

New approach to CAR T-cell therapy shows promise against small cell lung cancer in preclinical study

A new approach to chimeric antigen receptor T-cell (CAR T) therapy has shown great promise against small cell lung cancer (SCLC) in a preclinical study.

25 Apr 2023

Novel immunotherapy appears to be safe, well tolerated by children with relapsed brain tumors

The first in-human-study of a new immunotherapy that blocks a natural enzyme tumors commandeer for their protection was well tolerated by children with relapsed brain tumors and enabled many to have unexpected months of a more normal life, researchers say.

25 Apr 2023

New class of immunotherapy shows promise against aggressive skin cancer

A new class of immunotherapy shows promising results for fighting the most aggressive form of skin cancer.

25 Apr 2023

Immunotherapy News and Research

Latest Immunotherapy News and Research

AI-based population screening could expedite the diagnosis of pancreatic cancer

People with Long COVID neurological symptoms found to have differences in immune cell profiles and autonomic dysfunction

HIPEC: A promising treatment for certain patients with Stage IV abdominal cancer

Breast cancer tumors disrupt the development of an immune response to favor their own growth

Cancer stem cell test can lead to increased survival for patients with glioblastoma

Wistar scientists uncover a key mechanism as to how p53 suppresses tumors

Study finds a pharmacological-based approach to revert immune escape of breast cancer cells

Study pinpoints how gut microbes boost the body's response to cancer immunotherapy

New approach for efficient engineering of cell and gene therapies

Testing hundreds of existing therapeutics to fight blood cancer more effectively

Unique treatment can eradicate pancreatic tumors while stopping cancer progression

Melanoma research unveils landscape of DNA and RNA alterations across multiple organs of metastasis

Biomarker signature test can predict tumor response to bladder cancer immunotherapy

Developing Next-Generation Nanomaterials for Medical Applications

Spatial organization of immune cells predicts outcomes for patients with clear cell renal cell carcinoma

Research uncovers antibodies that are still effective against new variants of SARS-CoV-2

ASTRO/ESTRO's clinical guideline offers recommendations on the use of local therapy for oligometastatic NSCLC

New approach to CAR T-cell therapy shows promise against small cell lung cancer in preclinical study

Novel immunotherapy appears to be safe, well tolerated by children with relapsed brain tumors

New class of immunotherapy shows promise against aggressive skin cancer

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Immunotherapy News and Research

Latest Immunotherapy News and Research

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in